Cargando…

VEGF(121)b and VEGF(165)b are weakly angiogenic isoforms of VEGF-A

BACKGROUND: Different isoforms of VEGF-A (mainly VEGF(121), VEGF(165 )and VEGF(189)) have been shown to display particular angiogenic properties in the generation of a functional tumor vasculature. Recently, a novel class of VEGF-A isoforms, designated as VEGF(xxx)b, generated through alternative sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Catena, Raúl, Larzabal, Leyre, Larrayoz, Marta, Molina, Eva, Hermida, Jose, Agorreta, Jackeline, Montes, Ramon, Pio, Ruben, Montuenga, Luis M, Calvo, Alfonso
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022671/ https://www.ncbi.nlm.nih.gov/pubmed/21194429 http://dx.doi.org/10.1186/1476-4598-9-320

Ejemplares similares

The endogenous anti-angiogenic VEGF isoform, VEGF(165)b inhibits human tumour growth in mice
por: Rennel, E S, et al.
Publicado: (2008)

VEGF-A165 is the predominant VEGF-A isoform in platelets, while VEGF-A121 is abundant in serum and plasma from healthy individuals
por: Yamakuchi, Munekazu, et al.
Publicado: (2023)

Overexpression of VEGF(121), but not VEGF(165) or FGF-1, improves oxygenation in MCF-7 breast tumours
por: Fenton, B M, et al.
Publicado: (2004)

VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo
por: Rennel, E S, et al.
Publicado: (2009)

VEGF, VEGF165b and EG-VEGF expression is specifically related with hormone profile in pituitary adenomas
por: Corlan, Ana Silvia, et al.
Publicado: (2019)

The splicing factor YBX1 promotes the progression of osteosarcoma by upregulating VEGF(165) and downregulating VEGF(165b)
por: Quan, Bingxuan, et al.
Publicado: (2023)

Dynamics and implications of circulating anti-angiogenic VEGF-A(165)b isoform in patients with ST-elevation myocardial infarction
por: Hueso, Luisa, et al.
Publicado: (2017)

VEGF(165)b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
por: Varey, A H R, et al.
Publicado: (2008)

Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF(165)b Isoform in the Vitreous of Patients with Retinopathy of Prematurity
por: Zhao, Min, et al.
Publicado: (2015)

The role of VEGF-A(165)b in trophoblast survival
por: Bills, Victoria L, et al.
Publicado: (2014)

A multiscale computational model predicts distribution of anti-angiogenic isoform VEGF(165b) in peripheral arterial disease in human and mouse
por: Chu, Liang-Hui, et al.
Publicado: (2016)

Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma
por: Pritchard-Jones, R O, et al.
Publicado: (2007)

Systems Pharmacology of VEGF165b in Peripheral Artery Disease
por: Clegg, Lindsay E., et al.
Publicado: (2017)

Angiogenic Effects of Collagen/Mesoporous Nanoparticle Composite Scaffold Delivering VEGF(165)
por: Kim, Joong-Hyun, et al.
Publicado: (2016)

VEGF‐A(165)b protects against proteinuria in a mouse model with progressive depletion of all endogenous VEGF‐A splice isoforms from the kidney
por: Stevens, Megan, et al.
Publicado: (2017)

Effects of receptor tyrosine kinase inhibitors on VEGF(165)a- and VEGF(165)b-stimulated gene transcription in HEK-293 cells expressing human VEGFR2
por: Carter, Joanne J, et al.
Publicado: (2015)

Levels of vascular endothelial growth factor-A(165b) (VEGF-A(165b)) are elevated in experimental glaucoma
por: Ergorul, Ceren, et al.
Publicado: (2008)

Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential for the Activation of Lymphangiogenic VEGFs
por: Künnapuu, Jaana, et al.
Publicado: (2021)

Do Anti-Angiogenic VEGF (VEGFxxxb) Isoforms Exist? A Cautionary Tale
por: Harris, Sheila, et al.
Publicado: (2012)

Anti-angiogenic alternatives to VEGF blockade
por: Khan, Kabir A., et al.
Publicado: (2015)

Inhibition of retinal neovascularization by siRNA targeting VEGF(165)
por: Xia, Xiao-bo, et al.
Publicado: (2008)

Combined Transfer of Human VEGF165 and HGF Genes Renders Potent Angiogenic Effect in Ischemic Skeletal Muscle
por: Makarevich, Pavel, et al.
Publicado: (2012)

Angiogenic and pleiotropic effects of VEGF165 and HGF combined gene therapy in a rat model of myocardial infarction
por: Makarevich, Pavel I., et al.
Publicado: (2018)

Detection of VEGF-A(xxx)b Isoforms in Human Tissues
por: Bates, David O., et al.
Publicado: (2013)

Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-A(165)a, VEGF-A(165)b, PIGF and VE-cadherin
por: Pang, Vincent, et al.
Publicado: (2017)

Ovarian VEGF(165)b expression regulates follicular development, corpus luteum function and fertility
por: Qiu, Y, et al.
Publicado: (2012)

Targeting of Tumor Neovasculature with GrB/VEGF(121), a Novel Cytotoxic Fusion Protein
por: Mohamedali, Khalid A., et al.
Publicado: (2017)

An anti-angiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease
por: Kikuchi, Ryosuke, et al.
Publicado: (2014)

Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response
por: De Rosa, Lucia, et al.
Publicado: (2016)

Antiangiogenic VEGF Isoform in Inflammatory Myopathies
por: Volpi, Nila, et al.
Publicado: (2013)

Probing High Affinity Sequences of DNA Aptamer against VEGF(165)
por: Kaur, Harleen, et al.
Publicado: (2012)

Designing and Development of a Tandem Bivalent Nanobody against VEGF(165)
por: Khodabakhsh, Farnaz, et al.
Publicado: (2021)

VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164(b) therapy
por: Cromer, Walter E, et al.
Publicado: (2013)

Association between the ratio of anti-angiogenic isoform of VEGF-A to total VEGF-A and adverse clinical outcomes in patients after acute myocardial infarction
por: Harada, Kazuhiro, et al.
Publicado: (2018)

Investigation of Antiangiogenic Tumor Therapy Potential of Microencapsulated HEK293 VEGF(165)b Producing Cells
por: Afkhami, Fatemeh, et al.
Publicado: (2010)

Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
por: Markowska, Anna I., et al.
Publicado: (2010)

VEGF-A121a binding to Neuropilins – A concept revisited
por: Sarabipour, Sarvenaz, et al.
Publicado: (2017)

Binding of VEGF-A is sufficient to abrogate the disturbing effects of VEGF-B together with VEGF-A on retinal endothelial cells
por: Deissler, Heidrun L., et al.
Publicado: (2015)

Angiogenic Modification of Microfibrous Polycaprolactone by pCMV-VEGF165 Plasmid Promotes Local Vascular Growth after Implantation in Rats
por: Klabukov, Ilya, et al.
Publicado: (2023)

Targeting Anti-Angiogenic VEGF(165)b–VEGFR1 Signaling Promotes Nitric Oxide Independent Therapeutic Angiogenesis in Preclinical Peripheral Artery Disease Models
por: Kuppuswamy, Sivaraman, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u47mrk04m6odlvou7ugbuok224